Acadia Pharmaceuticals (ACAD) Debt to Equity (2010 - 2012)

Acadia Pharmaceuticals' Debt to Equity history runs 3 years deep, the most recent figure standing at $0.0 for Q1 2012.

• In Q1 2012, Debt to Equity changed N/A year-over-year to $0.0; the TTM figure through Mar 2012 stood at $0.0 (changed N/A YoY), while the FY2011 annual figure was $0.0, down 47.87% from the prior year.
• Debt to Equity was $0.0 for Q1 2012 at Acadia Pharmaceuticals, down from $0.0 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.0 in Q4 2010 to a low of $0.0 in Q2 2011.
• Historically, Debt to Equity has averaged $0.0 across 3 years, with a median of $0.0 in 2011.
• Biggest YoY gain for Debt to Equity was 47.87% in 2011; the steepest drop was 47.87% in 2011.
• A 3-year view of Debt to Equity shows it stood at $0.0 in 2010, then plunged by 47.87% to $0.0 in 2011, then fell by 8.66% to $0.0 in 2012.
• The last three Debt to Equity figures came in at $0.0 (Q1 2012), $0.0 (Q4 2011), and $0.0 (Q3 2011), per Business Quant data.